Condition-specific coaching and care AI
Lucia Health Coach
This profile covers Lucie on the Heart Rhythm Society’s UpBeat website, supported by BMS-Pfizer. It offers AFib education. Sponsorship is disclosed, but response sourcing, redirection, privacy behavior, and actual sponsor influence were not tested.
Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.
Summary judgment · 62 out of 100 toward patient-directed
Lucie on Heart Rhythm Society's UpBeat website for AFib education. Other Lucia provider workflows are outside this bounded deployment assessment.
Potentially agency-expanding
This profile covers Lucie on the Heart Rhythm Society’s UpBeat website, supported by BMS-Pfizer. It offers AFib education. Sponsorship is disclosed, but response sourcing, redirection, privacy behavior, and actual sponsor influence were not tested.
Patient agency
How this tool changes agency
Condition education can prepare discussion, but actual response provenance, alternative explanations and correction behavior are not established from terms.
Answer sourcing, user redirection, retention and sponsor influence in conversation remain unverified
Patient agency assessment
Who sets and changes the goal?
The public educational deployment offers a patient-initiated source of questions. Sponsor support alone does not establish direction toward a drug, nor do disclaimers prove users can redirect the bot.
What can the patient understand, question, or do?
Condition education can prepare discussion, but actual response provenance, alternative explanations and correction behavior are not established from terms.
Can the patient evaluate the conditions of use?
The collaboration and sponsor are visible on the terms page. Privacy behavior and in-chat sponsor visibility remain unknown, with no automatic penalty.
Text findings
Conditions of use
Published controls and their limits
The collaboration and sponsor are visible on the terms page. Privacy behavior and in-chat sponsor visibility remain unknown, with no automatic penalty.
What remains unknown?
Not tested or not established
Answer sourcing, user redirection, retention and sponsor influence in conversation remain unverified
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Answer sourcing, user redirection, retention and sponsor influence in conversation remain unverified No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
AI-assisted draft · Low to moderate for identified deployment and terms (AI-assisted draft)